We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 0.49% | 10.20 | 10.25 | 10.60 | 10.425 | 10.15 | 10.15 | 1,286,917 | 16:35:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -6.39 | 18.13M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/1/2021 16:50 | 1marcr, I never said you were aiming at anybody, that's why I asked who, appologies if it came across that way. It's just that you said "the comms that I have come across" | toyin | |
02/1/2021 16:38 | My comments weren't aimed at Elric, just how enthusiastic SA is about the trial (which as I CEO I guess he should be). My point was let's not get too excited just yet in case the trial isn't a success. | 1marcr | |
02/1/2021 16:09 | It is an if not when but winclove and prof cath are experts and must be happy with the method of action of the mix. Also this isn’t about a cure it’s about alleviating the symptoms., so it gives a real wide target of success. Even slight relief will be classed as successful when the price pitch is £1 per day. More to this than a pass or a fail imo. S | shrewdmole | |
02/1/2021 16:05 | 1marcr, I would like to know were your information comes from re the "if" and "when". I know from conversations and emails with Elric we are both in the "if" camp, from memory I dont remember SA every saying it was a "when" outcome. If it was a givin that it works what would be the need for the trials! Who are the people saying "when" and who is being lined up for a fall? | toyin | |
02/1/2021 15:20 | I think elrico eluded to this with a capital IF. and also stated it would represent a key DERISK moment. If that isn't a warning the human trials are not 100% certain to be a success i don't know what is. | slartybartfaster | |
02/1/2021 14:17 | Happy new year guys. I can understand where PJ is coming from. The comms that I have come across surrounding the upcoming psoriasis trail is not an 'if' the trial is successful but a 'when'. My worry as an investor is are we unintentionally being set up for a fall, if the trial doesn't work as hoped? On the flip side if the trial does work then I think we will all profit very handsomely from it. | 1marcr | |
02/1/2021 13:54 | PJ, ref AVA. It has. I have several PM's suggesting investment-grade activity. | elrico | |
02/1/2021 13:09 | refer to IMM. | pj 1 | |
02/1/2021 13:06 | Clearly indicating that you neither understand the science or the market. As Shrewd has already said..... one of the biggest and most successful UK businesses, Croda, a FTSE 100 company, have committed millions to a production line and you see the share price at 9p. That's without all of the other channels. Do us all a favour and sell your stock, if you actually hold any. | madaboutmed | |
02/1/2021 13:01 | shrewdie, yes fair comment, it was a little tongue in cheek, my comments were solely based on the spring trial. On a serious note I now prefer to base any estimates I have on tangible figures and official RNS statements. edit- as an aside, I'm astounded Elrics comments on AVA have not generated more interest in the Company. | pj 1 | |
02/1/2021 13:00 | PJ, you're the sort of person that can brighten up any room...once you've left! 🤣🤣 Can you please start a new, more positive 2021, if only for your sake. You're gonna give yourself ulcers they way you carry on, or worse, trick yourself into selling. | elrico | |
02/1/2021 12:54 | Pj I know your cynical but you seem to totally discount croda/sederma who have committed millions to a dedicated production line that has replicated the method of action. You’ve also totally discounted any further IP for hair and oral care, cleanbiotix or woundcare or any up front payments. Let’s not forget SA options kick in above 30p. | shrewdmole | |
02/1/2021 12:35 | Shrewd I can see us at 75p if everything goes according to plan. As we went up to around 27p not that long ago I think we could easily be twice that and more. Just for FUN. | 1crunchy | |
02/1/2021 12:18 | OK - 42p, but I think we will surpass 50p at some point earlier in the year, assuming positive news on the trial, of course. I hope your prediction is closer than mine though! | lovewinshatelosses | |
02/1/2021 11:52 | Right then following elrics tips let’s just for fun put a 31st December 2021 price guesstimate for sbtx!! I’m going for 85p. Like I say just for fun. S | shrewdmole | |
01/1/2021 23:37 | Donated today Elrico | robo28 | |
01/1/2021 22:23 | $ORPH $SNG $SBTX $DDDD $OPTI $AVA $PHE | elrico | |
01/1/2021 16:29 | Proactive are wrong. Elrico teases out the real time line though his relaxed approach allowing the CEO to talk freely without interruption. Both croda and winclove could have commercial products by October. Both limited 25k to 50k subscribers for the psoriasis and 12 VIP cosmetic brands. Listen to Stuart Ashman CEO SkinBioTherapeutics by lemming investors on #SoundCloudhTTps://s | slartybartfaster | |
01/1/2021 14:53 | Robbie, it is good exposure but its a bad article. It states: "This will commence in the first quarter of 2021. "If this is successful, AxisBiotix could become a commercial food supplement by early-2022. This is incorrect, if successful it will be commercial in Q3/Q4 2021 in limited numbers initially, between 25-50,000 subscribers. If we take the low figure of 25k that gives us £9.1m pa for starters. If 1% of the states use it, that is 80,000 people X £1 per day = £29.2m pa If 1% of the UK use it, that is 11,000 people X £1 per day = £4m pa If 1% of the world use it, that is 1.25m people X £1 per day = £456m pa SA did lay some of this out in his last interview with Elric. Apologies if my calcs are out, had a couple of glasses of Chablis😬 Happy New Year everyone. | toyin | |
01/1/2021 14:53 | The CEO SA needs to play this down and keep us in reality. This reminds me exactly of IMM a few years ago. Its pretty obvious to me what's going top happen here at some point. | pj 1 | |
01/1/2021 13:19 | Been tipped again for 2021. if the psoriasis trial delivers then the sky is the limit. If just 1% of the psoriasis group in the states start using the product then it will pull in around £11m per annum. It is the type of product that if it delivers the results we all hope then he uptake will be vastly more than 1%. Drop the rest of the world market in on top then it might be challenging to keep up with demand! Then we throw the Croda deal in and boom | robbieishere | |
31/12/2020 09:08 | Must be a large buy to be reported later. | rafboy | |
31/12/2020 09:05 | Don't see that very often. Bid and Offer both at 23p. | zedder |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions